SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (1959)4/9/2003 4:36:36 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 2243
 
Here's a Reuters blurb excerpt on the results.....

Abbott said it expects sales of Humira, which totaled $26 million in the latest quarter, to reach $200 million in 2003, up from its previous forecast of $150 million. It said it sees sales jumping to more than $500 million in 2004.

I may look for an op to add some to "2000". We'll see. As you know, I tend to tread lightly around MAb companies.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News